Amplia Therapeutics Limited

OTCPK:INNM.F Stock Report

Market Cap: US$48.3m

Amplia Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:INNM.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 Jun 26BuyUS$1,027,004Pengana Capital Ltd.Company8,734,045US$0.18
21 Jan 26SellUS$363,665Platinum Investment Management LimitedCompany3,631,139US$0.11
01 Sep 25BuyUS$19,661Jane BellIndividual130,435US$0.15
01 Sep 25BuyUS$22,937Warwick TongIndividual152,174US$0.15
01 Sep 25BuyUS$98,303Robert PeachIndividual652,174US$0.15
01 Sep 25BuyUS$13,107Christopher BurnsIndividual86,957US$0.15
29 Jul 25BuyUS$1,301,739Platinum Investment Management LimitedCompany8,695,653US$0.15
29 Jul 25BuyUS$65,087Allan MossIndividual434,783US$0.15

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of INNM.F?
Owner TypeNumber of SharesOwnership Percentage
Private Companies29,064,9145.66%
Individual Insiders69,888,17013.6%
Institutions76,200,64314.8%
General Public338,158,28765.9%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 31.7%.

Top Shareholders

Top 23 shareholders own 34.12% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.04%
Acorn Capital Limited
36,144,321US$3.4m0%6.64%
5.37%
Pengana Capital Ltd.
27,544,919US$2.6m104%10.09%
3.93%
Allan Moss
20,165,845US$1.9m0%no data
1.67%
HB Biotechnology Limited
8,562,431US$805.1k0%29.85%
1.46%
Mishtalem Pty Ltd
7,500,000US$705.2k0%no data
1.41%
Christian Behrenbruch
7,220,779US$679.0k28%no data
1.24%
James Simpson
6,347,826US$596.9k46%no data
1.2%
Heh Enterprises Pty
6,150,000US$578.3k0%no data
1.19%
Robert Peach
6,131,164US$576.5k0%no data
1.07%
Charbellu Pty Limited
5,500,000US$517.2k0%no data
0.93%
Sun Li
4,750,000US$446.6k0%no data
0.81%
Christopher Burns
4,155,574US$390.8k0%no data
0.79%
Peijun Zhang
4,053,470US$381.2k0%no data
0.77%
Harper Bernays Limited
3,948,972US$371.3k0%5.53%
0.77%
Ctx Crc Ltd
3,940,579US$370.5k0%no data
0.75%
Warwick Tong
3,864,073US$363.3k0%no data
0.71%
Jane Bell
3,661,751US$344.3k0%no data
0.66%
Julian Forby
3,404,178US$320.1k0%no data
0.58%
Robert Greenslade
3,000,000US$282.1k0%no data
0.58%
J&J Stuart Pty Ltd
3,000,000US$282.1k0%no data
0.58%
Dinwoodie Investments Pty Ltd
2,974,335US$279.7k0%no data
0.31%
Michael Whiting
1,566,755US$147.3k0%no data
0.31%
Tracey Whiting
1,566,755US$147.3k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/24 06:24
End of Day Share Price 2026/07/22 00:00
Earnings2026/03/31
Annual Earnings2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Amplia Therapeutics Limited is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Thomas WakimBell Potter